Lymphokine-activated Killer (LAK) Activity Against Autologous Malignant Tumors of the Skin

This publication has 17 references indexed in Scilit:

• Lymphokine-activated killer cells. Analysis of progenitors and effectors.
  The Journal of Experimental Medicine, 1986
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
  The Journal of Experimental Medicine, 1986
• Interleukin 2-activated killer cells: generation in collaboration with interferon? and its suppression in cancer patients
  Cancer Immunology, Immunotherapy, 1986
• Lymphokine activated killing of fresh human leukaemias
  Leukemia Research, 1986
• Phenotypic dynamics of tumor progression in human malignant melanoma
  International Journal of Cancer, 1985
• Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
  Cancer, 1985
• Regulation of Natural Killer Cell Function by Glass-adherent Cells in patients with Primary Intracranial Malignancies
  Neurosurgery, 1984
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques
  Pathology, 1983
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982